Kayne Anderson Rudnick Investment Management’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-97,218
Closed -$3.1M 970
2023
Q4
$3.1M Sell
97,218
-11,515
-11% -$362K 0.01% 317
2023
Q3
$3.84M Sell
108,733
-255
-0.2% -$9.72K 0.01% 306
2023
Q2
$4.14M Buy
108,988
+2,756
+3% +$110K 0.01% 309
2023
Q1
$4.01M Sell
106,232
-1,887
-2% -$72.5K 0.01% 303
2022
Q4
$4.58M Sell
108,119
-4,851
-4% -$200K 0.01% 300
2022
Q3
$3.63M Sell
112,970
-2,359
-2% -$82.8K 0.01% 303
2022
Q2
$3.75M Sell
115,329
-4,265
-4% -$138K 0.01% 296
2022
Q1
$4.33M Sell
119,594
-22,593
-16% -$775K 0.01% 282
2021
Q4
$5.63M Sell
142,187
-1,853
-1% -$77.3K 0.01% 273
2021
Q3
$6.29M Buy
144,040
+7,173
+5% +$322K 0.02% 258
2021
Q2
$5.59M Buy
136,867
+4,186
+3% +$162K 0.01% 261
2021
Q1
$4.36M Buy
132,681
+4,541
+4% +$171K 0.01% 265
2020
Q4
$5.21M Sell
128,140
-15,705
-11% -$587K 0.02% 253
2020
Q3
$5.27M Buy
143,845
+3,327
+2% +$120K 0.02% 239
2020
Q2
$4.76M Buy
140,518
+13,843
+11% +$377K 0.02% 225
2020
Q1
$2.68M Sell
126,675
-514
-0.4% -$11.5K 0.02% 243
2019
Q4
$2.84M Buy
127,189
+1,170
+0.9% +$25.5K 0.01% 247
2019
Q3
$2.55M Buy
+126,019
New +$2.48M 0.01% 251

Other funds holding GMAB

Kayne Anderson Rudnick Investment Management's GMAB Position: Q1 2024 in Review

Kayne Anderson Rudnick Investment Management sold out of Genmab (GMAB) in Q1 2024, closing a stake of 97,218 shares — an estimated $3.1M sold.

Kayne Anderson Rudnick Investment Management first reported a position in GMAB in Q3 2019 and held it in 18 quarters. The position peaked at $6.29M in Q3 2021. 228 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.

  • Kayne Anderson Rudnick Investment Management reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 97,218 Genmab shares in Q1 2024, an estimated $3.1M.
  • Kayne Anderson Rudnick Investment Management first reported a position in Genmab in Q3 2019 and held it in 18 quarters.
  • Kayne Anderson Rudnick Investment Management's Genmab position peaked at $6.29M in Q3 2021.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q1 2024.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2024, filed 14 May 2024.